跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Transtec - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Transtec
Approved
STANDARD
Transtec
LTS Lohmann Therapie-Systeme AG
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
0de3946e51c4ce28
Company
LTS Lohmann Therapie-Systeme AG
Type
Standard
Approval Details
Approval Id
0de3946e51c4ce28
Drug Approval Philippines Name
Transtec
Product Name
Transtec
Registration Number
DR-XY46027
Brand Name
Transtec
Generic Name
Buprenorphine
Dosage Form
Transdermal Patch
Dosage Strength
30 mg (52.5 mcg/h)
Manufacturer
LTS Lohmann Therapie-Systeme AG
Importer
Mundipharma Distribution GmbH (Philippine Branch)
Distributor
Mundipharma Distribution GmbH (Philippine Branch)
Company Detail Path
/organization/lts-lohmann-therapie-systeme-ag
Issuance Date
30 July 2024
Expiry Date
08 September 2027
Pharmacologic Category
Oripavine Derivative (Analgesic)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
0de3946e51c4ce28
Type
Standard
Back to Philippines FDA Approvals